Pulmonary delivery of a nerve agent neutralizing enzyme

Details for Australian Patent Application No. 2005274634 (hide)

Owner Nexia Biotechnologies, Inc.

Inventors Turner, Jeffrey Donald

Agent Spruson & Ferguson

Pub. Number AU-A-2005274634

PCT Pub. Number WO2006/017935

Priority 60/603,186 20.08.04 US; 11/195,041 02.08.05 US

Filing date 18 August 2005

Wipo publication date 23 February 2006

International Classifications

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 39/02 (2006.01) General protective or antinoxious agents

Event Publications

5 April 2007 PCT application entered the National Phase

  PCT publication WO2006/017935 Priority application(s): WO2006/017935

23 August 2007 Assignment before Grant

  Nexia Biotechnologies, Inc. The application has been assigned to PharmAthene Canada

28 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274636-Identity theft protection and notification system

2005274629-LED control utilizing dynamic resistance of LEDs